Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Medicenna is a clinical stage, privately held, immuno-oncology company.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
RA Capital Management has invested in 455 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post-IPO Equity round. RA Capital Management's total known invested capital is $44.0B.
RA Capital Management's average investment size is $125.7M across its portfolio of 455 companies.
Recent RA Capital Management portfolio additions include Jade Biosciences, Celcuity, Mineralys Therapeutics, Pyxis Oncology, Blueprint Medicines. These companies were founded in 2020 or later.